Dubai, UAE. SNS Research’s latest report indicates that global mHealth (mobile healthcare) revenue is expected to surpass $23 billion by the end of 2017.
As healthcare service providers seek to maximize their patient outreach while minimizing costs, many view mHealth as the solution to improve healthcare cost-efficiency. mHealth refers to the usage of mobile communications technology and devices to enhance access to healthcare information, improve distribution of routine and emergency health services, and provide diagnostic services.
Mobile operators also view mHealth as a lucrative opportunity for the monetization of their mobile connectivity services as a growing proportion of their subscribers adopt healthcare-centric wearables. Given that most operators have established themselves as reputable consumer brands, they are also eyeing opportunities to offer services beyond simple connectivity. Many operators already offer branded or cobranded end-to-end mHealth solutions to their customer bases.
In addition, mHealth offers a multitude of opportunities to the pharmaceutical industry ranging from enhanced R&D activities and medication adherence to securing the supply chain and combating counterfeit drugs.
Driven by the thriving ecosystem, SNS Research estimates that the mHealth market will account for over $23 billion in 2017 alone. Despite barriers relating to regulation, patient acceptance, and privacy concerns, SNS Research estimates further growth at a CAGR of more than 35% over the next three years.
The “mHealth (Mobile Healthcare) Ecosystem: 2017-2030—Opportunities, Challenges, Strategies & Forecasts“ report presents an in-depth assessment of the global mHealth market. In addition to covering key market drivers, challenges, future roadmap, value chain analysis, deployment case studies, service/product strategies, and strategic recommendations, the report also presents comprehensive forecasts for the mHealth market from 2017 to 2030. The forecasts and historical revenue figures are individually segmented for five individual submarkets, 29 use case categories, five ecosystem player categories, six geographical regions, and 34 countries.
The report will be of value to current and future potential investors into the mHealth sector, as well as enabling technology providers, mHealth device OEMs, mobile operators, healthcare providers, pharmaceutical companies, healthcare insurers, government healthcare institutions, application developers, and software/service vendors who wish to broaden their knowledge of the mHealth ecosystem.